Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...

Cancers that spread to the spine move to the bone marrow of the vertebral column by way of blood vessels. Spinal cord compression can also occur through direct tumor extension, which is frequently ...

Jan. 22, 2025 — Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more ... directing cells where to build the spine and nervous ...

New research suggests that electrical spinal cord stimulation could improve muscle function for patients who have spinal ...

More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

From stem cell research to spinal implants, here are three studies Becker's reported on since Jan. 15.

An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...

As ASC case volume grows, single-specialty ASCs have an opportunity to shine, spine surgeon Choll Kim, MD, said.

Spinal cord injury (SCI) remains the most serious complication of repairing descending thoracic and thoracoabdominal aortic aneurysms, with endovascular ...

Michael Markmiller was in excruciating pain for years. The 53-year-old couldn’t walk more than 100 meters without his legs ...

Multilevel decompression exhibited comparable postoperative outcomes with that of single-level decompression in patients with lumbar spinal stenosis.